Caring for Australians and New ZealandeRs with kidney Impairment guideline commentary on kidney disease: improving global outcomes 2025 guidelines for diagnosis and management of autosomal polycystic kidney disease. [PDF]
Abdy ME +16 more
europepmc +1 more source
Real-World Outcomes of Sodium-Glucose Cotransporter 2 Inhibitor Therapy in Nondiabetic Autosomal-Dominant Polycystic Kidney Disease: Effects on Progression to Dialysis in a TrinetX Cohort. [PDF]
Chang CH +7 more
europepmc +1 more source
Machine Learning Prediction of Progression to Dialysis in Patients With Polycystic Kidney Disease: Population-Based Retrospective Cohort Study. [PDF]
Chang CH +7 more
europepmc +1 more source
Dual Monogenic Cystic Disease Case Report: Autosomal Dominant Polycystic Kidney Disease and Autosomal Dominant Polycystic Liver Disease. [PDF]
Brossart AK +4 more
europepmc +1 more source
Clinical and Genetic Characterization of a Patient With SEC63-Related Autosomal Dominant Polycystic Liver Disease and an IFT140 Pathogenic Variant Associated With Polycystic Kidney Disease. [PDF]
Ortega-Macías AG +4 more
europepmc +1 more source
From data to drug: the translational impact of RaDaR, the UK national registry of rare kidney diseases. [PDF]
Gale DP.
europepmc +1 more source
Systemic inflammatory biomarkers linked to <i>PKD1</i> mutation and renal morphometrics in cats with polycystic kidney disease. [PDF]
Jaturanratsamee K +4 more
europepmc +1 more source
The Importance of Molecular Testing in the Diagnosis of Genetic Syndromes with Chronic Kidney Disease: Genotype-Phenotype Correlations. [PDF]
Butnariu LI +8 more
europepmc +1 more source
Bidirectional Mendelian randomization study reveals no causal association between polycystic ovary syndrome and IgA nephropathy. [PDF]
Wang X, Zhang R, Chai W, Peng X.
europepmc +1 more source

